Market Cap 39.58B
Revenue (ttm) 19.67B
Net Income (ttm) 1.99B
EPS (ttm) N/A
PE Ratio 19.02
Forward PE 17.67
Profit Margin 10.13%
Debt to Equity Ratio 1.18
Volume 2,708,800
Avg Vol 3,434,414
Day's Range N/A - N/A
Shares Out 455.52M
Stochastic %K 36%
Beta 1.08
Analysts Strong Sell
Price Target $91.45

Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning,...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 735 1139
Address:
500 West Monroe Street, Chicago, United States
ZacksResearch
ZacksResearch Jan. 12 at 2:23 PM
$TEM: Is it time to take profits after a 105% gain? 📈 Tempus AI has soared over the past year, driven by strong performance in its Genomics and Data segments, outperforming the industry, S&P 500, and rivals like $EXAS and $GEHC, thanks to FDA approvals and AI demand. Despite the positive adjusted EBITDA, GAAP losses and stock-based compensation remain concerns. See what could impact TEM's next move 👉 https://www.zacks.com/stock/news/2815490/tempus-ai-stock-rallies-105-in-a-year-should-investors-still-hold?cid=sm-stocktwits-2-2815490-body-28364&ADID=SYND_STOCKTWITS_TWEET_2_2815490_BODY_28364
0 · Reply
parcha
parcha Jan. 11 at 4:13 PM
$GEHC Stifel raised the firm’s price target on GE HealthCare (GEHC) to $95 from $90 and keeps a Buy rating on the shares. The firm, which argues that the 2026 setup is constructive for large-cap MedTech following 2025 pressures, adjusted targets among its coverage and highlights Boston Scientific (BSX), Edwards Lifesciences (EW), and Solventum (SOLV) as its three top ideas entering the year. https://finance.yahoo.com/news/ge-healthcare-price-target-raised-124143161.html
0 · Reply
parcha
parcha Jan. 10 at 8:43 PM
$GEHC this Tuesday
0 · Reply
parcha
parcha Jan. 10 at 8:42 PM
$GEHC Friday was Ex-Dividend Date 01/09/2026 · Dividend Yield 0.16% · Annual Dividend $0.14 . Payment Friday, Feb 13
0 · Reply
D6975
D6975 Jan. 9 at 11:32 PM
$GEHC why won’t this stock act more like $GE and $GEV
1 · Reply
parcha
parcha Jan. 8 at 6:51 PM
https://youtube.com/watch?v=vkHTvOVF-kc&si=osvLuYSUhP9f_Pw2 $GEHC Healthcare Sector (4:58-5:36): Newton sees good strength in healthcare, particularly in medical devices and biotech for long exposure over the next month. He suggests switching to a more pharma-centric approach thereafter. Overall, healthcare is not a true overweight and requires selectivity.
0 · Reply
parcha
parcha Jan. 7 at 3:17 AM
$GEHC https://finance.yahoo.com/news/nxp-ge-healthcare-accelerate-ai-160000907.html
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 4 at 5:19 PM
$GEHC GE HealthCare Technologies Inc (NASDAQ:GEHC) operates at the center of medical technology, patient monitoring equipment, diagnostic imaging, and digital solutions that enable hospitals and clinicians to improve outcomes and deliver better care across the world. https://biotechhealthx.com/biotech-news/why-ge-healthcare-technologies-gehc-could-be-the-hidden-giant-behind-the-future-of-global-healthcare/
0 · Reply
parcha
parcha Jan. 4 at 4:02 PM
$GEHC https://www.cnbc.com/nasdaq-100/ Member of nasdaq100
0 · Reply
parcha
parcha Jan. 2 at 10:25 PM
$GEHC GE HealthCare Technologies Inc. (NASDAQ:GEHC) is largely controlled by institutional shareholders who own 87% of the company https://finance.yahoo.com/news/ge-healthcare-technologies-inc-nasdaq-121336398.html
0 · Reply
Latest News on GEHC
GE HealthCare to Acquire Intelerad for $2.3 Billion

Nov 20, 2025, 5:43 PM EST - 7 weeks ago

GE HealthCare to Acquire Intelerad for $2.3 Billion


GE Healthcare to acquire Intelerad for $2.3 billion

Nov 20, 2025, 4:12 PM EST - 7 weeks ago

GE Healthcare to acquire Intelerad for $2.3 billion


Tariffs Bite Into GE HealthCare Q3 Profit Margin

Oct 29, 2025, 11:42 AM EDT - 2 months ago

Tariffs Bite Into GE HealthCare Q3 Profit Margin


GE HealthCare Tech Profit Slides as Tariffs Drag

Oct 29, 2025, 7:33 AM EDT - 2 months ago

GE HealthCare Tech Profit Slides as Tariffs Drag


GE HealthCare reports third quarter 2025 financial results

Oct 29, 2025, 6:20 AM EDT - 2 months ago

GE HealthCare reports third quarter 2025 financial results


GE HealthCare announces cash dividend for third quarter of 2025

Sep 24, 2025, 3:58 PM EDT - 3 months ago

GE HealthCare announces cash dividend for third quarter of 2025


GE Healthcare exploring sale of China unit, source says

Sep 19, 2025, 2:20 AM EDT - 4 months ago

GE Healthcare exploring sale of China unit, source says


GE HealthCare: This Drop Represents A Buying Opportunity

Jul 31, 2025, 3:48 AM EDT - 5 months ago

GE HealthCare: This Drop Represents A Buying Opportunity


GE HealthCare reports second quarter 2025 financial results

Jul 30, 2025, 6:20 AM EDT - 6 months ago

GE HealthCare reports second quarter 2025 financial results


ZacksResearch
ZacksResearch Jan. 12 at 2:23 PM
$TEM: Is it time to take profits after a 105% gain? 📈 Tempus AI has soared over the past year, driven by strong performance in its Genomics and Data segments, outperforming the industry, S&P 500, and rivals like $EXAS and $GEHC, thanks to FDA approvals and AI demand. Despite the positive adjusted EBITDA, GAAP losses and stock-based compensation remain concerns. See what could impact TEM's next move 👉 https://www.zacks.com/stock/news/2815490/tempus-ai-stock-rallies-105-in-a-year-should-investors-still-hold?cid=sm-stocktwits-2-2815490-body-28364&ADID=SYND_STOCKTWITS_TWEET_2_2815490_BODY_28364
0 · Reply
parcha
parcha Jan. 11 at 4:13 PM
$GEHC Stifel raised the firm’s price target on GE HealthCare (GEHC) to $95 from $90 and keeps a Buy rating on the shares. The firm, which argues that the 2026 setup is constructive for large-cap MedTech following 2025 pressures, adjusted targets among its coverage and highlights Boston Scientific (BSX), Edwards Lifesciences (EW), and Solventum (SOLV) as its three top ideas entering the year. https://finance.yahoo.com/news/ge-healthcare-price-target-raised-124143161.html
0 · Reply
parcha
parcha Jan. 10 at 8:43 PM
$GEHC this Tuesday
0 · Reply
parcha
parcha Jan. 10 at 8:42 PM
$GEHC Friday was Ex-Dividend Date 01/09/2026 · Dividend Yield 0.16% · Annual Dividend $0.14 . Payment Friday, Feb 13
0 · Reply
D6975
D6975 Jan. 9 at 11:32 PM
$GEHC why won’t this stock act more like $GE and $GEV
1 · Reply
parcha
parcha Jan. 8 at 6:51 PM
https://youtube.com/watch?v=vkHTvOVF-kc&si=osvLuYSUhP9f_Pw2 $GEHC Healthcare Sector (4:58-5:36): Newton sees good strength in healthcare, particularly in medical devices and biotech for long exposure over the next month. He suggests switching to a more pharma-centric approach thereafter. Overall, healthcare is not a true overweight and requires selectivity.
0 · Reply
parcha
parcha Jan. 7 at 3:17 AM
$GEHC https://finance.yahoo.com/news/nxp-ge-healthcare-accelerate-ai-160000907.html
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 4 at 5:19 PM
$GEHC GE HealthCare Technologies Inc (NASDAQ:GEHC) operates at the center of medical technology, patient monitoring equipment, diagnostic imaging, and digital solutions that enable hospitals and clinicians to improve outcomes and deliver better care across the world. https://biotechhealthx.com/biotech-news/why-ge-healthcare-technologies-gehc-could-be-the-hidden-giant-behind-the-future-of-global-healthcare/
0 · Reply
parcha
parcha Jan. 4 at 4:02 PM
$GEHC https://www.cnbc.com/nasdaq-100/ Member of nasdaq100
0 · Reply
parcha
parcha Jan. 2 at 10:25 PM
$GEHC GE HealthCare Technologies Inc. (NASDAQ:GEHC) is largely controlled by institutional shareholders who own 87% of the company https://finance.yahoo.com/news/ge-healthcare-technologies-inc-nasdaq-121336398.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 1 at 2:26 AM
$GEHC RSI: 38.77, MACD: 1.1562 Vol: 1.04, MA20: 83.47, MA50: 78.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
sirspanky
sirspanky Dec. 29 at 2:13 PM
$HCTI 🔥 $HCTI just leveled up its entire platform strategy. The company isn’t partnering with Ezovion like others do — it owns the HIS/EMR + AI engine outright. That means full control of: • hospital ops platform • AI automation (Readabl.ai) • CloudEz/DataEz data pipeline • NEW payment-gateway revenue coming • Cross-sell across 100+ hospital sites This goes way beyond analytics add-ons you see at $MDRX, $GEHC, or even SaaS players like $VEEV — HCTI now has the whole stack: data → AI → automation → billing. Undervalued, early, and in a sector that spends more during downturns to optimize margins.
1 · Reply
parcha
parcha Dec. 29 at 1:44 PM
$GEHC GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the JP Morgan 44th Annual Healthcare Conference in San Francisco, CA on January 13, 2026, at 10:30 a.m. PT/1:30 p.m. ET/12:30 p.m. CT. A webcast of this event can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-events/events on the date and time listed above. https://finance.yahoo.com/news/ge-healthcare-management-present-upcoming-130000771.html
0 · Reply
BooleanBets
BooleanBets Dec. 25 at 5:10 AM
$GEHC Strategic optionality narrows unless management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
JasonCO
JasonCO Dec. 24 at 7:57 PM
0 · Reply
Thtguyukno
Thtguyukno Dec. 22 at 10:58 PM
$GEHC the only laggard of the fam.
0 · Reply
JustTradingHoy
JustTradingHoy Dec. 22 at 10:15 PM
$GEHC it see $80 that needs to hold and bounce. Otherwise back to low $70S Same story for two years
0 · Reply
QuantumChallah
QuantumChallah Dec. 20 at 4:33 PM
$BEAT combining the ambulance business which could result in $250 price alone in a few years, this has a potential of $380-$500 in 3-5 years on a fully 3x diluted shares But what is working behind the scene now is to convince the founder to dilute the shares at an agreed price purchased by a big partnership. This wouldn't affect but benefit the current shareholders, however the percentage of shares by the founder will be diluted. This is the possible reason of delayed news on dilutions. The founder insisted on $15 for a smaller percentage of shares to be sold to the partnership, or $26 sold at a higher percentage of shares. I ain't know things. So let's don't assume a hostile bid war when GE Healthcare $GEHC is upset to drive out Samsung and Apple people. Just saying, WO
2 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:29 PM
$GEHC partners with Indonesia on massive healthcare initiative — big move for emerging markets! 🌍 🤝 Over 300 CT scanners to boost care for 280M people 🌐 Multi-year contract through a global tender process 📈 Shares up 14.4% in 6 months vs. industry’s 1.2% decline, while S&P 500 gained 16.6% Discover the full impact here 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-body-25255&ADID=SYND_STOCKTWITS_TWEET_2_2805793_BODY_25255
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 4:29 PM
Big move for $GEHC in emerging markets — and it’s about access, not hype 🏥🌏 GE HealthCare is partnering with Indonesia’s Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostic capabilities across public hospitals. See how this partnership broadens GEHC’s global healthcare footprint 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-teaser-25220&ADID=SYND_STOCKTWITS_TWEET_2_2805793_TEASER_25220
0 · Reply
Arunas1
Arunas1 Dec. 16 at 11:47 PM
$UNH $XLV $GEHC Tariffs coming for Healthcare Insurance next 1-2 weeks. Will be Damming and Damaging Inseance Industry $DIA
1 · Reply
ScreamLikeABaby
ScreamLikeABaby Dec. 16 at 2:25 PM
$SYK $TEM $GEHC Tempus has a projected earnings growth rate of 58.9% for 2025, higher than the industry’s 37% growth. The company has a favorable current cashflow rate of 267.2% against the industry’s 28.3%. TEM has a projected sales growth rate of 82.2% (for the current fiscal year) compared with the industry’s 3.6% growth
0 · Reply